Unilateral Primary Aldosteronism, Mineralocorticoid Antagonists Versus Surgical Treatment
Recruiting
N/A
Interventional Study
Primary Hyperaldosteronism Due to Adrenal Adenoma
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 70
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 80 (estimated)
- Sponsor
- Göteborg University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This is a prospective randomized controlled trial where quality of life and the effectiveness of treatment will be evaluated in 80 patients with confirmed unilateral primary aldosteronism ,randomly assigned to be either treated surgically with unilateral adrenalectomy or to receive medical treatment with eplerenone.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Patients with confirmed unilateral PA
2. Age 18-70 years
3. Candidate for surgical treatment
4. No contraindications for minimally invasive surgery or treatment with MRA
5. Understands oral and written information and provides oral and written informed consent.
Exclusion Cri…
Contacts